Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heart disease
Biotech
Cytokinetics' heart failure drug improves exercise capacity
Cytokinetics' cardiomyopathy drug has improved exercise capacity in a pivotal phase 3 trial, sending the biotech’s shares soaring.
Annalee Armstrong
Dec 27, 2023 8:43am
Eko AI spots murmurs at 2x the rate of other stethoscopes: study
Nov 14, 2023 10:11am
Roche signs onto Alnylam's midstage hypertension med for $310M
Jul 24, 2023 11:00am
BridgeBio heart disease med vindicated with phase 3 victory
Jul 17, 2023 10:12am
Acesion hits primary endpoint in midphase afib trial
Mar 14, 2023 6:00am
Bayer, Huma build online prediction tool for heart disease
Feb 6, 2023 9:53am